search
Back to results

Timing of Maternal Antibiotic Prophylaxis During a Cesarean Section and the Early Infant Gut Microbiome (CSBabyBiome)

Primary Purpose

Microbial Colonization, Antibiotic Side Effect, Cesarean Section Complications

Status
Completed
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Cefazolin
Sponsored by
University Medical Center Groningen
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Microbial Colonization

Eligibility Criteria

undefined - 1 Year (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Females undergoing elective CS at the UMCG Gestational age in weeks equal to or above 38 weeks Exclusion Criteria: Cephalosporin allergy Exposure to antibiotic agent 2 weeks before CS Temperature >37.5 C before CS Pre-labour rupture of membranes Emergency CS No -20 freezer at home No command of the Dutch language

Sites / Locations

  • University Medical Center Groningen

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Cord clamped after antibiotic prophylaxis

Cord clamped before antibiotic prophylaxis

Arm Description

Umbilical cord clamped after 1g of cephazolin

Umbilical cord clamped before 1g of cephazolin

Outcomes

Primary Outcome Measures

Infant microbial species level differences between two groups
Centered log ratio transformed relative abundance differences of bacterial species (relative abundance of > 0.05% and present in at least 2 infants) between two interventional groups
Infant Alpha Diversity differences between two groups
Alpha Diversity difference measured by the Shannon Diversity Index of infant microbiome at species level between two interventional groups
Infant Beta Diversity differences between two groups
Beta Diversity difference in Aitchison distances between the two intervention groups
Infant Antibiotic Resistance total gene load differences between two groups
Infant Antibiotic Resistance total gene load differenced measured in RPKM between the two interventional groups

Secondary Outcome Measures

Number of participants with post c-section maternal wound infection
Number of participants with early and late post C-section wound infection in mothers

Full Information

First Posted
August 25, 2023
Last Updated
September 11, 2023
Sponsor
University Medical Center Groningen
search

1. Study Identification

Unique Protocol Identification Number
NCT06030713
Brief Title
Timing of Maternal Antibiotic Prophylaxis During a Cesarean Section and the Early Infant Gut Microbiome
Acronym
CSBabyBiome
Official Title
Timing of Umbilical Cord Clamping During an Elective Caesarean Delivery and Its Association With Neonatal Gut Microbiome.
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Completed
Study Start Date
March 1, 2019 (Actual)
Primary Completion Date
October 1, 2022 (Actual)
Study Completion Date
March 1, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Medical Center Groningen

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
In this study, investigators seek to determine whether the timing of antibiotics given to mothers during an elective C-section affects the composition of their infant's gut microbiome. To do this, a randomized controlled trial (RCT) was carried out with women undergoing elective C-sections. These women were either given antibiotics before the skin incision (AB+) or after the umbilical cord was clamped (AB-).
Detailed Description
Rationale: During a caesarean delivery, umbilical cord clamping can occur before or after administering a perioperative prophylactic antibiotic to the mother. If the cord is clamped before the antibiotic administration, this antibiotic cannot reach the infant. Conversely, if the cord is clamped after the antibiotic administration, these maternal antibiotics cross the placenta and enter the infant's circulation. In this study, investigators hypothesize that such antibiotics modify the composition and functionality of the neonatal gut microbiome. A changed neonatal microbiome associates with the onset of asthma, allergies, type 1 diabetes, and obesity later in life. Such a small intervention could influence the future health of the infant significantly. Objective: The primary aim of this study is to contrast the composition and functionality of the neonatal gut microbiome from mothers given antibiotic prophylaxis before skin incision with the microbiome of neonates from mothers given the antibiotic after umbilical cord clamping during an elective caesarean delivery. Study design: Randomized controlled trial Study population: Pregnant women at >38 weeks of gestation undergoing elective caesarean section at the UMCG will be randomized into two groups. The gut microbiome of the neonates from both groups will be analyzed. Intervention: The timing of umbilical cord clamping differs between the two groups. One gram of Cefazolin (once, intravenous) will be administered to one group before skin incision, while 1g cefazolin will be given to another group after umbilical cord clamping during an elective caesarean section. Main study parameters/endpoints: The primary endpoint of this study is the variance in the composition and functionality of the neonatal gut microbiome over a year, contrasting neonates from mothers given antibiotic prophylaxis before skin incision with neonates from mothers given the antibiotic after umbilical cord clamping.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Microbial Colonization, Antibiotic Side Effect, Cesarean Section Complications

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Timing of umbilical cord clamping is different in the two arms. One gram of Cefazolin (once, intravenous) will be given to one group of women before skin incision compared to 1g cefazolin given to another group of women after umbilical cord clamping during an elective caesarean section.
Masking
Participant
Allocation
Randomized
Enrollment
33 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Cord clamped after antibiotic prophylaxis
Arm Type
Active Comparator
Arm Description
Umbilical cord clamped after 1g of cephazolin
Arm Title
Cord clamped before antibiotic prophylaxis
Arm Type
Experimental
Arm Description
Umbilical cord clamped before 1g of cephazolin
Intervention Type
Drug
Intervention Name(s)
Cefazolin
Other Intervention Name(s)
DB01327, J01DB04
Intervention Description
Cord clamping before or after antibiotic (cefazolin) prophylaxis
Primary Outcome Measure Information:
Title
Infant microbial species level differences between two groups
Description
Centered log ratio transformed relative abundance differences of bacterial species (relative abundance of > 0.05% and present in at least 2 infants) between two interventional groups
Time Frame
First 6 weeks of life
Title
Infant Alpha Diversity differences between two groups
Description
Alpha Diversity difference measured by the Shannon Diversity Index of infant microbiome at species level between two interventional groups
Time Frame
First 6 weeks of life
Title
Infant Beta Diversity differences between two groups
Description
Beta Diversity difference in Aitchison distances between the two intervention groups
Time Frame
First 6 weeks of life
Title
Infant Antibiotic Resistance total gene load differences between two groups
Description
Infant Antibiotic Resistance total gene load differenced measured in RPKM between the two interventional groups
Time Frame
First 6 weeks of life
Secondary Outcome Measure Information:
Title
Number of participants with post c-section maternal wound infection
Description
Number of participants with early and late post C-section wound infection in mothers
Time Frame
First 6 weeks of life

10. Eligibility

Sex
All
Maximum Age & Unit of Time
1 Year
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Females undergoing elective CS at the UMCG Gestational age in weeks equal to or above 38 weeks Exclusion Criteria: Cephalosporin allergy Exposure to antibiotic agent 2 weeks before CS Temperature >37.5 C before CS Pre-labour rupture of membranes Emergency CS No -20 freezer at home No command of the Dutch language
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Trishla Sinha, MD
Organizational Affiliation
University Medical Center Groningen
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Alexandra Zhernakova, MD/PhD
Organizational Affiliation
University Medical Center Groningen
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Medical Center Groningen
City
Groningen
ZIP/Postal Code
9713 GZ
Country
Netherlands

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
The sequencing data of the microbiome will be available for other researchers via EGA
IPD Sharing Time Frame
Data will become available upon publication
IPD Sharing Access Criteria
Must fill in the form that the data will be used for research purposes.

Learn more about this trial

Timing of Maternal Antibiotic Prophylaxis During a Cesarean Section and the Early Infant Gut Microbiome

We'll reach out to this number within 24 hrs